Format

Send to:

Choose Destination
See comment in PubMed Commons below
Can J Urol. 2005 Oct;12(5):2841-2.

Remission of hormone-refractory prostate cancer attributed to Essiac.

Author information

  • 1Division of Urology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.

Abstract

Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.

PMID:
16274521
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk